Nancy J. Hutson, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 10,000 shares at $1.45 ($15K) on 2019-11-18, disclosed to the SEC on 2019-11-18.
Open-market purchase of $14k BCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CLSD | BUY | 2023-10-04 | $9K | — | Filing → |
| BCRX | SELL | 2023-06-15 | $207K | — | Filing → |
| CLSD | BUY | 2022-11-21 | $40K | — | Filing → |